Skip to main content
Midas Edge

Surrozen IncDE

For the period ended Sep 30, 2024. Filed Nov 6, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Nov 6, 2024

SRZN$32.64+2.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 1. Unaudited Condensed Consolidated Statements of Operations

Condensed Consolidated Statements of Operations and Comprehensive Loss

(In thousands, except per share amounts)

Three Months Ended · Nine Months Ended
September 30,September 30,
2024202320242023
Collaboration and license revenue$10,000$—$10,000$—
Operating expenses:
Research and development5,2006,11215,78221,135
General and administrative3,5683,57211,16512,209
Restructuring—1,505—2,712
Total operating expenses8,76811,18926,94736,056
Income (loss) from operations1,232(11,189)(16,947)(36,056)
Interest income4316611,3061,831
Other (expense) income, net(3,097)8351396
Loss on issuance of common stock, pre-funded warrants and warrants——(20,397)—
Net loss(1,434)(10,445)(35,525)(34,129)
Unrealized (loss) gain on marketable securities, net of tax—(4)—242
Comprehensive loss$(1,434)$(10,449)$(35,525)$(33,887)
Net loss per share attributable to common stockholders, basic and diluted$(0.44)$(5.14)$(12.57)$(16.96)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted3,2282,0332,8262,012

Condensed Consolidated Statements of Stockholders’ Equity

Additional · Total
Common stock · paid-in · Accumulated · stockholders’
SharesAmountcapitaldeficitequity
Balance at December 31, 20232,063$—$259,630$(221,695)$37,935
Vesting of restricted stock units44————
Vesting of early exercised stock options——1—1
Stock-based compensation expense——1,030—1,030
Net loss———(8,830)(8,830)
Balance at March 31, 20242,107—260,661(230,525)30,136
Issuance of common stock in the Private Placement1,092————
Issuance of common stock upon employee stock purchase plan7—42—42
Stock-based compensation expense——1,145—1,145
Net loss———(25,261)(25,261)
Balance at June 30, 20243,206—261,848(255,786)6,062
Vesting of restricted stock units44————
Stock-based compensation expense——1,039—1,039
Net loss———(1,434)(1,434)
Balance at September 30, 20243,250$—$262,887$(257,220)$5,667

Condensed Consolidated Statements of Stockholders’ Equity

Additional · Accumulatedother · Total
Common stock · paid-in · comprehensive · Accumulated · stockholders’
SharesAmountcapitallossdeficitequity
Balance at December 31, 20222,006$—$254,895$(241)$(178,653)$76,001
Repurchase of early exercised stock options(1)—————
Vesting of early exercised stock options——13——13
Stock-based compensation expense——1,129——1,129
Other comprehensive income———191—191
Net loss————(14,297)(14,297)
Balance at March 31, 20232,005—256,037(50)(192,950)63,037
Issuance of common stock under employee stock purchase plan33—187——187
Vesting of early exercised stock options——8——8
Stock-based compensation expense——1,158——1,158
Other comprehensive income———55—55
Net loss————(9,387)(9,387)
Balance at June 30, 20232,038—257,3905(202,337)55,058
Issuance of common stock upon option exercises——3——3
Vesting of early exercised stock options——6——6
Stock-based compensation expense——913——913
Other comprehensive loss———(4)—(4)
Net loss————(10,445)(10,445)
Balance at September 30, 20232,038$—$258,312$1$(212,782)$45,531
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.